Newbury Pharmaceuticals ABNEWBRY 
$0.300.00%24h
0.00%24h
Global rank34170
Market cap$5.88M
Change 7d-1.90%
YTD Performance-1.27%
SP500 benchmarkUnderperform
P/E-0.30
P/S5.89
Revenue$996.72K
Earnings-$1.89M
Dividend yield-
Main Sector
Healthcare
Newbury Pharmaceuticals AB (NEWBRY) Stock Overview
Newbury Pharmaceuticals AB (publ) operates as hybrid pharmaceutical company in Sweden, and Scandinavian market. It offers oncology, rare diseases, neurology, and other treatment products. The company was incorporated in 2020 and is based in Lund, Sweden.
NEWBRY Stock Information
Symbol
NEWBRYAddress
Scheeletorget 1Lund, 223 81Sweden
Founded
-Trading hours
-Website
https://www.newburypharma.comCountry
🇸🇪 SwedenPhone Number
46 46 12 11 20Newbury Pharmaceuticals AB (NEWBRY) Price Chart
-
Value:-
Newbury Pharmaceuticals AB Overview: Key Details and Summary
Stock data | 2023 | Change |
|---|---|---|
| Price | $0.3009781790820166 | N/A |
| Market Cap | $5.88M | N/A |
| Shares Outstanding | 19.52M | 0.00% |
| Employees | 6.00 | N/A |
| Shareholder Equity | 49.38M | -28.20% |
Valuation | 2023 | Change |
|---|---|---|
| P/E Ratio | -0.30 | N/A |
| P/S Ratio | 5.89 | N/A |
| P/B Ratio | 0.12 | N/A |
Growth | 2023 | Change |
|---|---|---|
| Return on Equity | -0.0382 | N/A |
Earnings | 2023 | Change |
|---|---|---|
| Revenue | $996.72K | N/A |
| Earnings | -$1.89M | N/A |
| EPS | -0.9954 | N/A |
| Earnings Yield | -3.31 | N/A |
| Gross Margin | 0.3846 | N/A |
| Operating Margin | -1.68 | N/A |
| Net income margin | -1.89 | N/A |
Financial Strength | 2023 | Change |
|---|---|---|
| Total Assets | $7.08M | N/A |
| Cash on Hand | $827.98K | N/A |
| Debt to Equity | 0.0463 | 80.76% |
| Current Ratio | $2.31 | -61.56% |
